首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates.
【24h】

Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates.

机译:冬凌草甲素作为潜在的抗癌药物候选物的新型1-O-和14-O-衍生物的合成及生物学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Novel 1-O- and 14-O-derivatives of oridonin were synthesized and biologically evaluated. All of the derivatives exhibited stronger cytotoxicity against six cancer cell lines (BGC-7901, SW-480, HL-60, BEL-7402, A549, and B16) than oridonin in vitro, and some of them were more potent than oridonin and cyclophosphamide in vivo. Compounds Ib and IIg were the most potent with the IC(50) values of 0.84 microM for Ib in HL-60 cell and 1.00 microM for IIg in BEL-7402 cell.
机译:合成了冬凌草甲肽的新型1-O-和14-O衍生物并对其进行了生物学评估。所有这些衍生物在体外对六种癌细胞系(BGC-7901,SW-480,HL-60,BEL-7402,A549和B16)均显示出比Oridonin更强的细胞毒性,其中一些比Oridonin和环磷酰胺更有效体内。化合物Ib和IIg最有效,HL-60细胞中Ib的IC(50)值为0.84 microM,BEL-7402细胞中IIg的IC(50)值为1.00 microM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号